MedTrace Logo

Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery

NCT02921230 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 775

Last updated 2025-02-24

Study results available
· View outcomes & findings →

Summary

The EMINENT study is a prospective, multi-center study evaluating the effectiveness of the ELUVIA stent versus Self-Expanding Bare Nitinol Stents in the treatment of lesions in the femoropopliteal arteries.

Conditions

  • Arterial Occlusive Diseases
  • Atherosclerosis
  • Vascular Diseases
  • Arteriosclerosis

Interventions

DEVICE

Peripheral stenting

stent implantation during the index procedure

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Giovanni Torsello, MD · Sint-Franziskus-Hospital GmbH

  • Yann Goueffic · Hôpital St Joseph Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-25
Primary Completion
2021-07-02
Completion
2023-11-06

Countries

  • Austria
  • Belgium
  • France
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02921230 on ClinicalTrials.gov